Adult psychiatric disorders characterized by cognitive deficits reliant on prefrontal cortex (PFC) dopamine are promoted by teenage bullying. Similarly, male SpragueDawley rats exposed to social defeat in mid-adolescence (P35-39) show impaired working memory in adulthood (P56-70), along with decreased medial PFC (mPFC) dopamine activity that results in part from increased dopamine transporter-mediated clearance. Here, we determined if dopamine synthesis and D2 autoreceptor-mediated inhibition of dopamine release in the adult mPFC are also enhanced by adolescent defeat to contribute to later dopamine hypofunction. Control and previously defeated rats did not differ in either DOPA accumulation following amino acid decarboxylase inhibition (NSD-1015 100 mg/kg ip.) or total/phosphorylated tyrosine hydroxylase protein expression, suggesting dopamine synthesis in the adult mPFC is not altered by adolescent defeat. However, exposure to adolescent defeat caused greater decreases in extracellular dopamine release (measured using in vivo chronoamperometry) in the adult mPFC upon local infusion of the D2 receptor agonist quinpirole (3 nM), implying greater D2 autoreceptor function. Equally enhanced D2 autoreceptormediated inhibition of dopamine release is seen in the adolescent (P40 or P49) mPFC, which declines in control rats by adulthood. However, this developmental decrease in autoreceptor function is absent following adolescent defeat, suggesting retention of an adolescent-like phenotype into adulthood. Current and previous findings indicate adolescent defeat decreases extracellular dopamine availability in the adult mPFC via both enhanced inhibition of dopamine release and increased dopamine clearance, which may be viable targets for improving treatment of cognitive deficits seen in neuropsychiatric disorders promoted by adolescent stress.
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| INTRODUCTION
Repeated bullying victimization currently affects more than 20% of teenagers from 10 to 14 years of age worldwide (Martin, Mullis, Foy, & Hooper, 2016) and greatly increases both adolescent and adult risk of subsequent psychopathology, including anxiety, depression, attention deficit disorder, substance use disorders, schizophrenia, and suicidality (Arseneault, Bowes, & Shakoor, 2010; Copeland, Wolke, Angold, & Costello, 2013; Fite, Evans, Cooley, & Rubens, 2014; Niemela et al., 2011; Tharp-Taylor, Haviland, & D'Amico, 2009; Trotta et al., 2013) . However, specific neural substrates that are affected by teenage bullying to potentiate emergence of such a wide range of neuropsychiatric disorders are not well understood. Developing a more complete understanding of precisely how the developing adolescent brain is disrupted by social stress is critical for identifying defined therapeutic targets for the effective treatment of bullyingassociated disorders.
The dopaminergic system of the medial prefrontal cortex (mPFC) appears to be particularly vulnerable to stress exposure during periadolescence (pre-through late adolescence, approximately postnatal day [P] 21-50 in rats; Watt, Weber, Davies, & Forster, 2017) , including experience of social aggression, with altered function noted in adulthood well after stressor cessation (reviewed in Watt et al., 2017) . Importantly, cognitive functions reliant on optimal PFC dopamine signaling, such as working memory, impulse control, and behavioral flexibility (Floresco, 2013) , are disrupted in bullying-associated disorders (Baune, Fuhr, Air, & Hering, 2014; Etkin, Gyurak, & O'Hara, 2013; Green, 2006; Lewandowski et al., 2016) . Long-term dysfunction in the mPFC dopamine system may reflect stress-induced alteration to key regulators of synaptic dopamine availability and postsynaptic dopamine signaling. For instance, exposure to social defeat in adolescence (P35-39) increases dopamine transporter (DAT)-mediated clearance in the adult mPFC (Novick et al., 2015) , while social isolation of disrupted-inschizophrenia-1 (DISC1) transgenic mice from P35 through to sampling in adulthood (P56) causes decreases in mPFC expression of tyrosine hydroxylase (TH) (Niwa et al., 2013) , the rate-limiting enzyme in catecholamine synthesis (Levitt, Spector, Sjoerdsma, & Udenfriend, 1965; Nagatsu, Levitt, & Udenfriend, 1964) . Extracellular dopamine availability in the mPFC is also tightly regulated by presynaptic dopamine D2 autoreceptors (Galloway, Wolf, & Roth, 1986) , which function to inhibit further dopamine release (Westfall, Besson, Giorguieff, & Glowinski, 1976) . Total expression of D2 receptors (pre-and postsynaptic combined) in the adult mPFC is either increased or decreased by adolescent exposure to social isolation (from P21-34, Han, Li, Xue, Shao, & Wang, 2012) and predator odor (from P40-48, Wright, Hebert, & Perrot-Sinal, 2008) , respectively, although presynaptic mPFC D2 receptor expression is not altered by isolation rearing from P23 until testing at P78 (Fitzgerald, Mackie, & Pickel, 2013) . However, no studies have examined whether the release-modulating properties of D2 autoreceptors in the adult mPFC are altered by experience of social stress in adolescence.
Adolescent male rats exposed to social defeat in the prepubertal period (P35-39, Korenbrot, Huhtaniemi, & Weiner, 1977) , as a model of teenage bullying, display enhanced behavioral responses both to amphetamine (Burke, Forster, Novick, Roberts, & Watt, 2013; Burke, Watt, & Forster, 2011) and to novelty (Watt, Burke, Renner, & Forster, 2009) in adulthood (P56-70), along with impaired working memory (Novick, Miiller, Forster, & Watt, 2013) . These behavioral alterations are reminiscent of those seen in bullying-associated neuropsychiatric disorders and indicate disrupted mPFC dopamine activity (Clark & Noudoost, 2014; Steketee, 2003; Yates et al., 2014) . In line with this, adolescent defeat decreases dopamine activity in the adult (P56) mPFC (Watt et al., , 2014 , which is mediated, in part, by increased DAT expression and function in the infralimbic region of the mPFC (Novick, Forster, Tejani-Butt, & Watt, 2011; Novick et al., 2015) . A role for altered D2 autoreceptor function in contributing to later cortical dopamine hypofunction is also implied, as pharmacological blockade of mPFC D2 autoreceptors during the adolescent defeat experience prevents the decrease in dopamine activity at P56 (Watt et al., 2014) . Further, this decrease in adult mPFC dopamine activity can be replicated in the absence of any social stress by repeated pharmacological activation of mPFC D2 autoreceptors during the same period of adolescence (P35-39; Watt et al., 2014) . Activation of D2 autoreceptors directly increases DAT-mediated dopamine clearance (Cass & Gerhardt, 1994; Schmitz, Schmauss, & Sulzer, 2002) , which may explain the observed increase in adult mPFC DAT function (Novick et al., 2015) . Enhanced D2 autoreceptor inhibition of dopamine release combined with greater DAT-mediated dopamine clearance may also increase presynaptic dopamine concentrations to enhance end-product inhibition of TH activity and decrease dopamine synthesis (Almas, Le Bourdelles, Flatmark, Mallet, & Haavik, 1992; Galloway et al., 1986) , which could also be potentiated by a loss of phosphorylation at several serine residues, particularly serine 40 (Salvatore, Waymire, & Haycock, 2001) . Together, this suggests that both persistently enhanced D2 autoreceptor function and dampened TH activity contribute directly to the reduction in dopamine availability in the adult mPFC caused by adolescent defeat.
Here, we used to in vivo amino acid decarboxylase inhibition and western immunoblotting to determine if adolescent social defeat decreases TH activity in the adult mPFC. In addition, in vivo chronoamperometry was used to test the hypothesis that D2 autoreceptor function in the mPFC at P56 is enhanced by adolescent defeat, as reflected by larger decreases in extracellular dopamine upon local infusion of a D2 receptor agonist. We also measured autoreceptor function at one (P40: mid-adolescence, pre-pubertal, Korenbrot et al., 1977) and ten days (P49: late adolescence, postpubertal, Korenbrot et al., 1977) after defeat exposure, to establish a developmental trajectory of changes to autoreceptor-mediated inhibition of dopamine release both following adolescent defeat and under normal control conditions. To our knowledge, this is the first study to examine function of release-modulating D2 autoreceptors between P40 and P56, expanding the understanding of the developing mPFC dopamine system. Our findings further implicate the negative effects of adolescent social stress on well-defined mechanisms known to regulate normal adult mPFC dopamine activity and suggest that mPFC D2 autoreceptors may represent potential targets for the treatment of bullying-associated neuropsychiatric disorders.
| MATERIAL AND METHODS

| Animals
Male Sprague-Dawley rats (total n = 187) were received on the day of weaning (P21) from the University of South Dakota (USD) Animal Resource Center's in-house breeding colony ( Figure 1 ) and were pair housed according to adolescent treatment group (adolescent defeat or control) for the duration of the experiments. In addition, adult male Sprague-Dawley rats also obtained from the USD Animal Resource Center were individually housed and served as aggressive residents for the adolescent social defeat procedure. All rats were maintained at 22°C on a reverse 12-hr light-dark cycle (lights off at 10:00). Food and water were available ad libitum throughout. The adolescent social defeat paradigm was conducted between 11:00 and 15:00 under red lighting. All procedures were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and received approval from the USD Institutional Animal Care and Use Committee. Every effort was made to minimize the number of animals used and their suffering.
| Adolescent social defeat
The adolescent social defeat paradigm utilized a modified resident-intruder paradigm described previously (Novick et al., 2015; Watt et al., 2009) . In brief, pre-pubertal (Korenbrot et al., 1977) male rats at P35 (mid-adolescence; Spear, 2000) were exposed to physical aggression from a larger (>300 g) adult male Sprague-Dawley resident rat for 10 min and were then isolated behind a wire mesh barrier within the resident's cage for an additional 25 min before returning to their home cage with their original cage mate. Adolescents (n = 95) were exposed to social defeat once per day for 5 days (P35-39, Figure 1 ) and confronted with a different resident male each day to control for differences in defeat intensity. Age-matched controls (n = 95) that did not undergo social defeat were placed into a novel empty cage for the duration of the defeat procedure to control for handling and novel environment stress. After the final defeat trial, all rats were returned to their home cage in their original pairs until further testing. For measures of mPFC TH activity, all subjects were allowed to mature undisturbed until P56 (adulthood, Figure 1 ). To examine mPFC D2 autoreceptor function following adolescent defeat or control conditions, in vivo electrochemistry testing was conducted at either P40 (mid-adolescence, pre-pubertal), P49 (late adolescence, postpubertal) or P56 (Figure 1 ). These time points were chosen as the adolescent defeat experience has been shown previously to alter medial prefrontal cortex (mPFC) dopamine activity at P40, P49, and P56 compared to controls (Watt et al., 2014) .
| Measurement of mPFC tyrosine hydroxylase activity
For measures of tyrosine hydroxylase (TH) activity, all subjects were sacrificed through decapitation and brains were rapidly removed, placed on dry ice, and stored at −80°C F I G U R E 1 Timeline of experimental procedures. P = postnatal day, TH = tyrosine hydroxylase until coronal sectioning at 300 μm using a cryostat (Leica Jung CM 1800; North Central Instruments, Plymouth, MN, USA). Sections were thaw-mounted on glass slides and stored at −80°C until bilateral microdissection of the mPFC (identified using Paxinos & Watson, 1998 ) using a 23 gauge cannula and freezing stage (Physiotemp; North Central Instruments).
| In vivo amino acid decarboxylase inhibition
Tyrosine hydroxylase activity was measured by in vivo accumulation of L-3,4-dihydroxyphenylalnine (DOPA) after pharmacological blockade of amino acid decarboxylase (AADC) (Carlsson, Davis, Kehr, Lindqvist, & Atack, 1972; Pascucci et al., 2012) . In adulthood (≥P56), subjects previously exposed to adolescent social defeat (n = 46) or control conditions (n = 46) received a single injection of either the AADC inhibitor, NSD-1015 (100 mg/kg ip., n = 23/control or defeat) or vehicle (phosphate buffered saline, n = 23/control or defeat). Thirty or 180 min after drug administration, subjects were sacrificed as described above. After microdissection, tissue was expelled into 60 μl of sodium acetate buffer (pH 5.0) containing 0.1 μM of internal standard (α-methyl-dopamine), and the cells were lysed by freeze-thawing samples. Accumulation of DOPA was determined using high performance liquid chromatography with electrochemical detection (HPLC-ED). Further details of this assay have been published elsewhere (Renner, Krey, & Luine, 1987; Scholl, Feng, Watt, Renner, & Forster, 2009; Scholl, Renner, Forster, & Tejani-Butt, 2010) . In brief, 2 μl of a 1 mg/ml ascorbate acid oxidase solution was added to each sample, which was then centrifuged at 17 000 g for 10 min. The supernatant was then removed and 50 μl injected into an HPLC system (Waters 717 Plus Autosampler, Waters Associated, Inc., MA, USA) and analyzed electrochemically with a LC-4B potentiostat and a glassy carbon electrode (BioAnalytical Systems, IN, USA). The electrode potential was set at +0.75 V with respect to a Ag/AgCl reference electrode. The mobile phase, which was optimized for detection of DOPA, consisted of 28 g citric acid, 17.2 g sodium acetate, 380 mg sodium octanesulfonate, 500 mg EDTA disodium salt, and 250 ml of methanol in 1 L of deionized water (all obtained from Sigma-Aldrich, St. Louis, MO, USA) Flow rate was maintained at 1.1 ml/ min. The remaining tissue pellet for each sample was dissolved in 110 μl of 0.4 M NaOH, and protein content was determined using the Bradford method (Bradford, 1976) . Concentrations of DOPA were obtained and corrected for recovery using CSW32 v1.4 Chromatography Station for Windows (DataApex, Prague, Czech Republic), and expressed as pg amine/μg protein.
| Ex vivo western immunoblot
Following either adolescent social defeat (n = 11) or control conditions (n = 10), subjects were sacrificed in adulthood (≥P56) and tissue collected and processed as described above. Microdissected mPFC tissue from individual subjects was added to a HEPES/Protease Inhibitor cocktail and cells lysed through sonication. Using commercially available primary and secondary antibodies, mPFC samples were probed for phosphorylated serine 40 (pSer40) TH protein levels (rabbit antipSer40 TH; 1:500, Cat. # AB5935; Millipore, Temecula, CA, USA), total TH protein levels (mouse anti-TH, 1:1000, Cat. # T2928, Sigma-Aldrich), and β-actin protein levels (loading control; mouse anti-actin, 1:2000, Cat. # MAB1501R; Millipore). Secondary antibodies include IRDye800-conjugated antirabbit (1:1000, Cat. # 611-132-122) and IRDye800-conjugated anti-mouse (1:2000 or 1:5000, Cat. # 610-145-121) both obtained from Rockland Immunochemicals Inc. (Gilbertsville, PA, USA). The previously lysed samples were loaded onto an 8% SDS-polyacrylamide gel and transferred to a PVDF membrane. General procedures for detection of each protein of interest include blocking with either 5% Bovine Serum of Albumin in Tris-Buffered Saline (TBS) or 5% non-fat dry milk in TBS at 4°C overnight, incubation in primary antibody for approximately 20 hr at 4°C, and then incubation in appropriate secondary antibody for two hours at room temperature. Following each secondary antibody incubation, the Odyssey Infrared Imaging System (Li-Cor Biosciences, Inc, Lincoln, NE, USA) was used to image and collect optical densitometry for each band. While the molecular weight of pSer40 TH appeared at the expected 62 kDa, total TH in the mPFC was detected at a higher weight of 75 kDa. We tested our primary antibody for total TH (same lot number) in striatal and accumbal tissue, where total TH was revealed at 62 kDa (data not shown). However, as in the mPFC, total TH in hippocampal tissue also appeared at 75 kDa (not shown), suggesting TH weight as determined by western blot is region-dependent. While it is not clear if this difference in kDa weight translates into any functional differences, here we chose to interpret the higher weight as still being representative of total TH expression in the mPFC.
| Measurement of D2 autoreceptor function
| Non-recovery stereotaxic surgery and in vivo electrochemistry
At approximately P40 (n = 19), P49 (n = 20), or P56 (n = 35), separate groups of previously defeated rats and their agematched controls underwent non-recovery stereotaxic surgery. Rats were anaesthetized with urethane (P40: 1.0 g/kg, P49: 1.2 g/kg, P56: 1.5 g/kg), a long lasting anesthetic that has minimal effect on neurotransmitter release and neuronal firing rates (Maggi & Meli, 1986) , and which does not interfere with dopamine measurements made using in vivo chronoamperometry procedures similar to those employed here (Sabeti, Gerhardt, & Zahniser, 2003) . Upon cessation of pedal withdrawal and eye blink responses, rats were mounted in a stereotaxic frame (David Kopf Inst, CA, USA) with the incisor bar set at approximately −0.3 mm, −1.3 mm, and −3.3 mm for P40, P49, and P56, respectively. Body temperature was maintained at 37°C throughout via a heating pad (Harvard Apparatus, Holliston, MA, USA).
Extracellular dopamine levels were measured using in vivo chronoamperometry procedures utilizing a three electrode system described in more detail previously (Forster & Blaha, 2003; Novick et al., 2015) . In brief, recordings of dopamine oxidation current were made using custom made stearate-modified graphite paste electrochemical recording electrodes (recording surface diameter, 200 μm). The addition of stearate to the graphite paste shifts the oxidation potential of competing compounds such as ascorbate and norepinephrine to more positive values, minimizing their interference and allowing resolution of a distinct dopamine signal (Blaha, 1996; Novick et al., 2015) . To confirm selective detection of a measurable dopamine oxidation current, electrodes were tested in vitro by recording voltammetric sweeps (−0.15 V -+0.45 V vs. Ag/AgCl, ramp rate 0.01 V/s; Blaha & Jung, 1991) with systematic addition of exogenous ascorbic acid (250 μM), dopamine (1 μM increments), and norepinephrine (1 μM increments). The greatest oxidation current for dopamine was found to be between −0.15 V and +0.15 V, while norepinephrine and ascorbic acid oxidized at +0.2 V -+0.35 V and >+0.4 V, respectively. This allowed identification of these compounds in vivo, while demonstrating selectivity of the electrode for a dopamine signal.
A Ag/AgCl reference electrode was placed in contact with cortical tissue contralateral to the recording electrode, with a stainless steel auxiliary electrode fixed to the skull. Recording electrodes were implanted directly into the left or right infralimbic mPFC in a counterbalanced manner within all adolescent stress, age, and drug infusion groups. A stainless steel guide cannula (26 gauge, laboratory made) was also implanted so that the end of the infusion cannula was approximately 0.5-1.0 mm dorsal to the working electrode. Coordinates varied among age groups to ensure correct placement in the infralimbic mPFC (P40: AP: +2.7 mm from bregma, ML ±0.5 mm from midline, DV = −4.2 mm from dura, P49: AP: +2.9 mm from bregma, ML ±0.5 mm from midline, DV = −4.4 mm from dura, P56: AP: +3.0 mm from bregma, ML ±0.5 mm from midline, DV = −4.5 mm from dura). The infralimbic mPFC was chosen based on previous studies showing that dopamine transporter (DAT) expression/function is increased after adolescent social defeat specifically in this mPFC subregion (Novick et al., 2011 (Novick et al., , 2015 . In addition, there is a direct positive relationship between D2 autoreceptor activation and DAT trafficking and function (Bolan et al., 2007; Cass & Gerhardt, 1994; Schmitz et al., 2002) , suggesting changes to D2 autoreceptors following adolescent defeat would also be localized to the infralimbic mPFC.
Thirty minutes after electrode implantation, an electrometer (Echempro, GMA Technologies, Inc., Vancouver, BC, Canada) was used to evaluate the viability of the graphite paste electrode for dopamine signal by recording several voltammetric sweeps within the infralimbic mPFC. Once the voltammetric range of a distinct dopamine signal was confirmed (Figure 2 ), similar to that seen in prior in vitro testing, the electrometer was set to make repetitive chronoamperometric measurements of dopamine oxidation current. In brief, a potential pulse of 1 s duration from −0.15 V to +0.15 V vs Ag/AgCl was applied to the recording electrode every 30 s to ensure selectivity of dopamine, with oxidation current being monitored at the end of each 1 s pulse. Thirty minutes of stable baseline measurements were taken prior to all pharmacological manipulations.
| Intra-mPFC drug infusion for D2 autoreceptor function
The effect of local mPFC infusion of quinpirole (D2 receptor agonist) was first investigated in previously defeated rats and their age-matched controls at P56, to test the hypothesis that adolescent defeat results in greater D2 autoreceptor function in the adult mPFC. To minimize the number of animals used in this study, rats first received infusions into the infralimbic mPFC of vehicle (artificial cerebral spinal fluid, aCSF, 0.5 μl over one minute), with dopamine oxidation measured for 60 min. The dopamine signal was then allowed to return to a stable baseline for a further 30 min before quinpirole infusions were made, with a decrease in mPFC dopamine oxidation upon drug delivery serving as a measure of D2 autoreceptor activation. Previous research has shown that activation of presynaptic release-modulating dopamine D2 autoreceptors through local infusion of 10 nM quinpirole can effectively inhibit restraint-induced increases in PFC dopamine release, while a subthreshold dose of 3 nM quinpirole is less effective (Doherty & Gratton, 1999) . Therefore, P56 subjects received intra-mPFC quinpirole infusions of either 3 or 10 nM/0.5 μl aCSF, with the prediction that the lower concentration would more effectively decrease dopamine oxidation in previously defeated rats compared to controls, reflecting greater sensitivity and activation of mPFC D2 autoreceptors. Quinpirole hydrochloride was dissolved in aCSF and aliquoted into concentrations of either 6 nM or 20 nM/1 μl aCSF and stored at −80°C, then thawed on the day of testing to allow for infusion of either 3 nM or 10 nM/0.5 μl aCSF. All infusions were made in volumes of 0.5 μl over one minute. Chronoamperometric measurements continued for 60 min following quinpirole infusion, with rats then euthanized with a lethal dose of Euthanasia-III Solution (1.0 ml, ip. Med-Pharmex, Pomona, CA, USA).
Analyses within the P56 age group showed that only previously defeated rats exhibited decreases in dopamine in response to 3 nM quinpirole, while decreases were elicited by the 10 nM dose in both stress groups, suggesting that the 3 nM quinpirole was a subthreshold dose that would be the most appropriate to elucidate potential differences in D2 autoreceptor function at earlier age points following experience of adolescent defeat. Therefore, dopamine oxidation was measured in separate groups of previously defeated rats and their age-matched controls at either P40 or P49 in response to vehicle infusion followed by 3 nM quinpirole only, using procedures identical to those described above.
| Histology
Immediately after euthanasia, brains were removed and fixed in 10% formalin prior to coronal sectioning at 60 μm. Recording electrode and infusion cannula placements were confirmed by two separate experimenters, one blind to treatment conditions. Only rats with infralimbic mPFC electrode placement were used for subsequent data analysis.
| Data analysis
All statistical tests were completed using either SPSS Statistics 24 (IBM Corp., Armonk, New York, NY, USA) or SigmaPlot v13.0 (Systat Software Inc., San Jose, CA, USA) with alpha level set at 0.05 throughout.
| Tyrosine hydroxylase activity
The effects of adolescent stress and AADC inhibition on DOPA accumulation in the mPFC were analyzed using a three-way ANOVA (adolescent stress × drug treatment × time). Significant interactions among factors were further analyzed with separate two-way ANOVA followed by SNK tests for multiple comparisons. Grubbs' outlier tests to remove significant outliers were performed prior to the above analyses (Grubbs, 1986) resulting in the removal of data from two control rats and two previously defeated rats.
Optical densitometry values collected from total TH were normalized to β-actin to determine total TH protein levels. In addition, pSer40 TH densitometry was normalized to total TH as a measure of TH activity. All values were expressed as a percentage of the adolescent control group. Separate one-way ANOVA were used to determine any differences between previously defeated and control rats.
| D2 autoreceptor function
Thirty minutes of baseline recordings following electrode implantation were normalized to zero current values, with changes following vehicle infusion presented as absolute changes in dopamine oxidation current (Forster & Blaha, 2003; Novick et al., 2015) and recordings then collapsed into five minute bins. Similar to that, responses to quinpirole were calculated with respect to normalized zero current values, but using baseline recordings obtained in the 30 min prior to drug infusion. Data sets obtained from individual subjects were excluded either if placement of the working electrode was not in the infralimbic region of the mPFC, or if no drug effect was observed.
F I G U R E 2 In vivo voltammetric
sweep recorded from the rat infralimbic medial prefrontal cortex before chronoamperometric measurements. Identification of peaks was accomplished by prior in vitro testing using systemic additions of known compounds to the test solution. Note that stearate-modification of the electrode ensures that the oxidation potentials for norepinephrine (+200 mV to + 350 mV) and ascorbic acid (>+400 mV) signals are shifted to more positive values and distinct from the applied potential used to detect dopamine (−150 mV to + 150 mV)
To compare the magnitude of changes to mPFC dopamine signal following infusion at P56, area under the curve (AUC) was calculated for all treatment groups and compared using a two-way ANOVA (adolescent stress × drug treatment), followed by Student-Newman Keuls (SNK) tests for multiple comparisons to identify differences at each drug dose. Differences across time within each level of drug were determined by separate two-way mixed design ANOVA (adolescent stress × repeated measure of time). Interactions between adolescent stress and time were further analyzed with post hoc SNK tests to determine differences between adolescent stress (control and defeat) at each time point. Main effects of time were followed by separate post hoc Holm-Sidak tests for multiple comparisons to identify significant changes across time within each quinpirole dose (0, 3, or 10 nM), using the sample immediately preceding infusion (−5 min) as the control dopamine value.
At P40 and P49, separate three-way mixed design ANOVA (adolescent stress × drug treatment × repeated measure of time), and adjusted for non-sphericity using a GreenhouseGeisser correction, were used to determine if dopamine responses after 3 nM quinpirole administration differed between previously defeated and control rats. Drug × time interactions were further analyzed by two-way mixed design ANOVA (repeated measure of time) performed separately for either P40 or P49. Main effects of time were followed by separate post hoc Holm-Sidak tests to identify significant changes across time within each quinpirole dose (0 or 3 nM) as described above.
A three-way mixed design ANOVA (stress × age × repeated measure of time) was used to determine if changes in dopamine signal over time in response to 3 nM quinpirole differed as a function of either age (P40, P49, or P56) or exposure to adolescent defeat. A significant age × time interaction was analyzed by two-way mixed design ANOVA (age × repeated measure of time) to examine differences among P40, P49, and P56 separately within each adolescent stress condition (defeat or control) over time, followed by SNK tests to compare dopamine responses across ages at each time point. 
| mPFC TH protein levels at P56 (early adulthood)
Previous exposure to adolescent defeat did not alter either total TH or phosphorylated serine 40 (pSer40) TH protein levels in the mPFC (Figure 3b ). Separate one-way ANOVA revealed no significant main effect of adolescent stress on either total TH protein levels (F 1,19 = 0.392, p = 0.539) or pSer40 TH protein levels (F 1,19 = 0.0428, p = 0.838).
| mPFC D2 autoreceptor function
| Histology
The electrode recording surfaces ranged in location between 2.7 mm and 3.2 mm anterior to bregma and were placed within the entire mediolateral and dorsoventral aspects of the infralimbic region of the medial prefrontal cortex (mPFC) across all subjects (Figure 4 ). There were no apparent differences in electrode placement either between previously defeated and control rats or among drug treatment groups.
| mPFC dopamine responses to 3 and 10 nM quinpirole at P56 (early adulthood)
Quinpirole infusion into the mPFC had differential effects on the magnitude of changes to dopamine signal (calculated as AUC) in controls and previously defeated rats at age P56, which were also dependent on drug dose (Figure 5a ). Twoway ANOVA revealed a significant adolescent stress × drug treatment interaction (F 2,32 = 7.102, p = 0.003). Responses to vehicle infusion did not differ between previously defeated and control rats (SNK, p ≥ 0.691). Within controls, infusion of 10 nM quinpirole reduced dopamine relative to both vehicle (SNK, p ≤ 0.001) and 3 nM quinpirole (SNK, p = 0.005), but responses to vehicle and 3 nM quinpirole did not differ (SNK, p = 0.381). In contrast, previously defeated rats showed a significant reduction in the magnitude of dopamine response upon 3 nM quinpirole infusion compared to controls (SNK, p ≤ 0.001). This response in defeated rats was also greater than that caused by vehicle infusion (SNK, p 0.001), but was equivalent to that induced by 10 nM quinpirole (SNK, p = 0.144). Responses to 10 nM quinpirole did not differ between defeated rats and controls (SNK, p = 0.992).
Differences between control and defeated rats with regard to changes in dopamine signal over time were further investigated using separate two-way mixed design ANOVA within each level of drug (0, 3, 10 nM). For vehicle infusion in control and previously defeated rats (Figure 5b ), no interaction between adolescent stress and time was detected (F 18,216 = 0.346, p = 0.994), but there was a gradual decrease in dopamine signal across time (F 18,216 = 1.719, p = 0.038). However, post hoc Holm-Sidak tests failed to detect differences from pre-infusion values at any subsequent time point (p ≥ 0.2), so this effect was likely due to a (Figure 5c ), two-way mixed design ANOVA revealed a stress × time interaction (F 18,186 = 15.215, p ≤ 0.001), with defeated rats at P56 exhibiting a significantly lower dopamine signal than controls at all time points from 5 min onward (SNK, p ≤ 0.001). In contrast, comparison of dopamine responses to 10 nM quinpirole at P56 (Figure 5d ) revealed a significant effect of time (F 18,174 = 21.208, p ≤ 0.001), but no stress × time interaction (F 18,174 = 0.59, p = 0.886), indicating equivalent decreases in dopamine over time in both groups at this higher dose. Post hoc Holm-Sidak tests revealed differences from pre-infusion values in both control and defeated rats beginning at 5 min postinfusion (p ≤ 0.004).
| mPFC dopamine responses to 3 nM quinpirole at P40 (Mid-Adolescence) and P49 (Late Adolescence)
Alterations in mPFC dopamine levels upon local infusion of 3 nM quinpirole were present in both previously defeated and control rats when measured at either P40 or P49. For rats at age P40 (Figure 6a ), three-way mixed design ANOVA revealed only an interaction between drug and time ( 
| Effects of 3 nM quinpirole at P40 within stress groups
Subsequent two-way mixed design ANOVA within P40 control subjects (Figure 6a ) indicated a drug × time interaction (F 18,216 = 5.757, p ≤ 0.001), such that infusion of vehicle into the mPFC had no effect on dopamine levels over time (F 18,108 = 0.451, p = 0.972), whereas 3 nM quinpirole caused a reduction in dopamine levels from baseline (F 18,108 = 15.959, p ≤ 0.001) from 10 to 60 min (HolmSidak, p ≤ 0.01). These reductions in dopamine resulting from 3 nM quinpirole produced values significantly lower than those following vehicle infusion at all time points from 25 min onwards (SNK, p ≤ 0.025).
Defeated rats at age P40 (Figure 6a ) showed similar drug × time-dependent decreases in dopamine (F 18,306 = 6.94, p ≤ 0.001), with no effect of vehicle infusion (F 18,162 = 0.189, p = 1.0) but reductions upon infusion of 3 nM quinpirole (F 18,144 = 12.594, p ≤ 0.001). As for control rats, effects of quinpirole in defeated rats at P40 began at 10 min (Holm-Sidak, p ≤ 0.013), but caused significant decreases in dopamine compared to vehicle from 15 min throughout (SNK, p ≤ 0.013).
| Effects of 3 nM quinpirole at P49 within stress groups
For P49 control subjects (Figure 6b ), two-way mixed design ANOVA showed a drug × time interaction (F 18,198 = 6.525, p ≤ 0.001). As for younger (P40) rats, controls at age P49 exhibited no change in dopamine over time with vehicle infusion (F 18,108 = 1.123, p = 0.341), but experienced reductions in dopamine upon 3 nM quinpirole infusion (F 18,90 = 13.111, p ≤ 0.001) beginning at 10 min (Holm-Sidak, p ≤ 0.045) that were significantly lower than vehicle from 25 min onwards (SNK, p ≤ 0.025).
Likewise, for defeated rats at P49 (Figure 6b ) there was an interaction between drug and time (F 18,216 = 8.989, p ≤ 0.001), with vehicle infusion again having no effect (F 18,90 = 0.865, p = 0.62), while 3 nM quinpirole resulted in decreased dopamine from pre-infusion levels (F 18,126 = 16.716 , p ≤ 0.001) starting at 10 min and persisting throughout (Holm-Sidak p ≤ 0.01), with values being significantly lower than for vehicle infusion from 20 min onwards (SNK p ≤ 0.028).
| mPFC dopamine responses to 3 nM quinpirole across age
Dopamine responses to local infusion of 3 nM quinpirole also varied as a function of age, as revealed by three-way mixed design ANOVA (adolescent stress × age × repeated measure of time). As dopamine levels did not differ from baseline following vehicle infusion within any age/stress group, this analysis was restricted to data from the 3 nM quinpirole infusion only. There was a significant age × time interaction (F 2.76,49 .67 = 4.160, p = 0.012), but no interaction either between adolescent stress and time (F 1.38,49 .67 = 0.24, p = 0.7) or among stress, age, and time (F 2.76,49.67 = 1.03, p = 0.38). Subsequent two-way mixed design ANOVA (repeated measure of time) to examine the age × time interaction were then conducted separately within each stress group. For control rats (Figure 7a ), this showed a significant interaction between age and time (F 36,288 = 4.597, p ≤ 0.001), such that dopamine responses to 3 nM quinpirole across time appeared to diminish with increasing age. This was supported by pairwise comparisons across age at each time point, which revealed greater decreases in dopamine signal at P40 compared to P49 (40 min and beyond, SNK, p ≤ 0.047), at P49 compared to P56 (35 min and beyond, SNK, p ≤ 0.029), and at P40 compared to P56 (15 min and beyond, SNK, p ≤ 0.019). However, within previously defeated rats (Figure 7b) , only a significant main effect of time was observed (F 18,360 = 33.207, p ≤ 0.001) but no significant age × time interaction (F 36,360 = 1.168, p = 0.239), indicating infusion of 3 nM quinpirole caused similar decreases in defeated rats regardless of age at sampling.
| DISCUSSION
In the current study, we show that exposure to defeat in pre-pubertal adolescence (P35 to P39) increases mPFC D2 autoreceptor function at P56 (adulthood). In contrast, adolescent defeat did not have meaningful effects on TH activity at the same age. In accordance with other studies (Pascucci et al., 2012) , the effect of AADC inhibition increased with time compared to vehicle treatment, but there was no difference between controls and previously defeated rats. This lack of change to in vivo TH activity is further corroborated by the finding that no changes to either total or pSer40 TH protein levels in the mPFC at P56 were evident following exposure to adolescent defeat. Together, these results suggest that decreased synthesis does not contribute to dopaminergic hypofunction in the adult mPFC caused by adolescent social defeat. However, further studies examining possible changes to phosphorylation of other serine residues would be of benefit in confirming the current findings, given pSer19 and 31 have been shown to play prominent roles in regulating TH activity (Damanhuri et al., 2012; Salvatore, Calipari, & Jones, 2016) .
Following adolescent defeat (P35-39), increased mPFC D2 autoreceptor function at P56 was reflected by a greater decrease in dopamine signal over time following 3 nM quinpirole infusion compared to controls. This lower dose of drug was completely ineffective in reducing dopamine in controls at age P56, consistent with previous work showing that 3 nM quinpirole does not prevent restraint-induced increases in mPFC dopamine (Doherty & Gratton, 1999) . However, controls did exhibit reductions in extracellular dopamine upon infusion of the higher dose (10 nM), which were equivalent to those seen in defeated rats at this dose, indicating intact autoreceptor function. Given the similarity in response to 10 nM quinpirole, potential differences between control and defeated rats at P40 or P49 were assessed using the lower 3 nM dose. In contrast to findings with rats at P56, autoreceptor function did not differ at these earlier ages, despite the fact that dopamine activity remains elevated at these time points F I G U R E 7 Effect of 3 nM quinpirole infusion on extracellular dopamine (DA) across time in the infralimbic medial prefrontal cortex (mPFC) when measured at either P40 (mid-adolescence), P49 (late adolescence), or P56 (adulthood). Note that these data are also shown in Figures 5C and 6 , but here are depicted separately for control (a) and defeated (b) rats. Data are expressed as mean change ± SEM in dopamine oxidation current (nA). Arrows represent time of intra-mPFC infusion. δ Significant difference between P40 and P49 (p < 0.05). # Significant difference between P40 and P56 (p < 0.05). * Significant difference between P49 and P56 (p < 0.05). Inset: Magnitude of changes to extracellular dopamine in the infralimbic mPFC of control (a) or previously defeated (b) rats following 3 nM quinpirole infusion at either P40, P49, or P56. Data are expressed as mean area under the curve (AUC) ± SEM of changes in dopamine signal from 0 to 59.5 min following drug infusion at age P40, P49, and P56. Separate one-way ANOVA revealed a significant effect of age in control rats (F 2,19 = 5.701, p = 0.013), but no difference was observed in previously defeated rats (F 2,21 = 1.916, p = 0.175)
following adolescent defeat (Watt et al., 2014) . This suggests that increased autoreceptor function does not occur in parallel with the developmental trajectory of dopamine activity changes caused by adolescent defeat, but instead manifests after continued elevations in activity.
Previous studies using other paradigms of adolescent stress exposure have found either increases or decreases in total mPFC D2 receptor expression in adulthood (Han et al., 2012; Wright et al., 2008) , which could potentially explain differences in autoreceptor-mediated extracellular dopamine. However, the current finding that defeated rats did not show additional decreases in dopamine compared to controls in response to the higher quinpirole dose argues against the observed difference being a result of increased D2 autoreceptor expression. This is supported by earlier findings from our laboratory demonstrating no difference in D2 receptor protein expression in the mPFC at P56 following adolescent defeat, although it should be noted that this study, like those by Wright et al. (2008) and Han et al. (2012) , did not differentiate between the pre-and postsynaptic forms of the receptor (Burke et al., 2011) . Therefore, we hypothesize that the underlying change to mPFC D2 autoreceptor function at P56 resulting from adolescent defeat is driven by enhanced responses to exogenous and endogenous ligands. Similarly, male rats perinatally exposed to Δ 9 -THC show sensitized behavioral responses to low doses of quinpirole at P70, which was interpreted as reflecting increased autoreceptor function following a developmental insult (Moreno, Trigo, Escuredo, Rodriguez de Fonseca, & Navarro, 2003) . Greater D2 autoreceptor function enhances inhibition of voltage-gated calcium channels, decreasing vesicular docking at the membrane and augmenting the prevention of dopamine release (Herlitze et al., 1996; Ikeda, 1996) . Our results suggest that the greater D2 autoreceptor function observed in previously defeated rats translates to enhanced inhibition of dopamine release in the mPFC, as is seen in the nucleus accumbens of mice (Karkhanis, Rose, Huggins, Konstantopoulos, & Jones, 2015) and non-human primates (Siciliano et al., 2016) following repeated ethanol exposure. Together with increased mPFC DAT expression/function (Novick et al., 2011 (Novick et al., , 2015 , greater D2 autoreceptor function and enhanced inhibition of dopamine release could contribute to the dopaminergic hypofunction in the adult mPFC caused by adolescent defeat (Watt et al., 2014; see Figures 8 and 9) . Here, we also established the functional development of mPFC D2 autoreceptors with regard to modulation of dopamine release under normal control conditions from mid-adolescence (P40) to adulthood (P56), which to our knowledge has never been studied. Further, we found that this developmental trajectory appears to be disrupted by exposure to adolescent defeat (Figure 8) . In control rats, the greatest decreases in dopamine in response to 3 nM quinpirole were seen at P40, with this response declining through P49 to P56, whereupon the quinpirole-induced decrease in dopamine was not significantly different from that seen upon vehicle infusion. In contrast, rats exposed to adolescent defeat exhibited equivalent responses to 3 nM quinpirole at all three ages, suggesting stress-induced disruption to the normal pattern of maturation. The developmental decrease in releasemodulating effects of mPFC D2 autoreceptors from P40 to P56 shown by controls contrasts with the trajectory of mPFC D2 receptor expression in rats, which appears to be maintained from P35 to P60 (Tarazi, Tomasini, & Baldessarini, 1998) , suggesting that receptor expression does not always reveal differences in function. In our study, responses to 3 nM quinpirole at P40 and P49 did not differ as a function of adolescent defeat. However, it is possible that the sensitivity of D2 autoreceptors with regards to release modulation is naturally higher at younger ages, which could have masked potential differences caused by adolescent defeat at P40. Support for this idea comes from the finding that the ability of D2 autoreceptors to directly suppress dopamine synthesis in the rat mPFC declines from P10 to P40 (Andersen, Dumont, & Teicher, 1997) . Therefore, further studies employing a lower dose of quinpirole should be carried out to confirm our finding that exposure to adolescent defeat does not alter D2 autoreceptor regulation of dopamine release prior to adulthood.
The differences to mPFC D2 autoreceptor function resulting from adolescent defeat may actually represent retention of an adolescent-like phenotype into adulthood, with autoreceptor function failing to mature fully. This concept is reflected in other measures of dopaminergic signaling and dopamine-modulated behavior. Specifically, we have shown that rats defeated in adolescence have higher expression of dopamine D1 receptors in the caudate putamen at P56 compared to controls (Novick et al., 2011) , which possibly indicates a lack of D1 receptor pruning that normally occurs from adolescence to adulthood (Andersen et al., 1997; Teicher, Andersen, & Hostetter, 1995) . In addition, in response to low dose (1.0 mg/kg) amphetamine, previously defeated rats show both greater conditioned place preference and increased locomotion at P56 (Burke et al., 2011 (Burke et al., , 2013 , which parallels the differences in these measures seen between adolescent and adult rats (Yates, Beckmann, Meyer, & Bardo, 2013) . Likewise, adolescent rats show deficits in working memory performance compared to adults (Koss, Franklin, & Juraska, 2011) , similar to the working memory impairments displayed by adult rats that had been exposed to adolescent defeat .
Adolescent rats display stress-evoked increases in mPFC dopamine release during the defeat experience (Watt et al., 2014) , similar to adult rats undergoing social defeat (Tidey & Miczek, 1996) . This presumably results in repeated activation of mPFC D2 autoreceptors, as supported by the finding that the dopaminergic hypofunction at P56 is prevented by blocking these receptors during the adolescent defeat experience (Watt et al., 2014) . In addition, the increased mPFC dopamine activity caused by adolescent defeat persists to P49 in the absence of any further stress, before declining below control levels at P56 (Watt et al., 2014) . The maintenance of elevated mPFC dopamine activity from P40 to P49 in defeated rats suggests sensitizing of the mPFC dopamine system, which resembles the lack of a habituated mPFC dopamine response seen in adult rats exposed to repeated social defeat (Holly, DeBold, & Miczek, 2015) , and implies further continued activation of D2 autoreceptors. Although enhanced autoreceptor-mediated inhibition may represent a mechanism to restore mPFC dopaminergic homeostasis, the repeated activation of these receptors in the absence of further stress leads to a sensitizing in release-modulating function, eventually resulting in a maladaptive state at P56 and ultimately causing a reduction in mPFC dopamine activity (Figure 8 ). Additional support for this comes from the finding that direct pharmacological activation of mPFC D2 autoreceptors in defeat-naïve adolescent rats recapitulates the decrease to mPFC dopamine activity at P56 observed after adolescent defeat (Watt et al., 2014) . Moreover, in the current study, we did not observe enhanced autoreceptor function following adolescent defeat until P56, implying that any increase in sensitivity requires a prolonged activation of autoreceptors before functional effects are evident.
While this study aimed to determine differences in D2 autoreceptor function, it is possible that other mechanisms may have contributed to the differences in dopamine signal observed between previously defeated and control rats at P56. Quinpirole is a mixed D2/3 agonist, with a higher affinity for D3 receptors (Sokoloff et al., 1992) , and presynaptic D3 autoreceptors have been shown to inhibit dopamine release in the juvenile (P15) rat mPFC to a greater degree than D2 autoreceptors (Andersen et al., 1997) . Therefore, observed changes to dopamine release in our study may have been preferentially driven by D3 autoreceptors. However, the functional outcome would still be the same, in that a greater decrease in dopamine signal would represent enhanced autoreceptor activity regardless of isoform. Differential effects of quinpirole-elicited activation of D2/3 autoreceptors following adolescent defeat may have also resulted from the increased mPFC DAT expression/function shown previously (Novick et al., 2011 (Novick et al., , 2015 . Activation of D2 autoreceptors can directly influence DAT function through a number of mechanisms (Figure 9 ), including enhanced DAT transcription via stress-evoked increases in activity of the nuclear F I G U R E 8 Hypothesized sequence of events occurring within the medial prefrontal cortex (mPFC) dopamine (DA) system after adolescent defeat exposure. Adolescent defeat (P35-39) increases mPFC DA activity at P40 and P49 (Watt et al., 2014) . We hypothesize that the resulting over-activation of mPFC D2 autoreceptors (D2AR) results in increased D2AR function in early adulthood, causing greater inhibition of DA release. Previous research has shown that D2AR activation increases DAT expression/function (↑: Cass & Gerhardt, 1994) , which may contribute to the enhanced DAT-mediated DA clearance following adolescent defeat (Novick et al., 2015) . Together, the reduced DA release and increased clearance results in reduced adult mPFC synaptic DA activity at P56 (Watt et al., , 2014 . Alterations resulting from defeat exposure are in bold and underlined (Defeat). * Indicates currently untested alterations that may be occurring after adolescent defeat exposure orphan receptor Nurr1 (Kim et al., 2006; Rojas, Joodmardi, Perlmann, & Ogren, 2010; Sacchetti, Mitchell, Granneman, & Bannon, 2001) , promoting recruitment of DAT to the plasma membrane through direct protein-protein interactions (Lee et al., 2007) , and by enhancing ERK1/2 signaling (Owens et al., 2012) . Given that membrane trafficking and enhanced signaling of ERK1/2 and Nurr1 can occur rapidly (Lee et al., 2007; Owens et al., 2012; Rojas et al., 2010) , it is possible that the observed difference to dopamine signal after 3 nM quinpirole is at least partially mediated through a rapid increase in DAT function. Regardless, greater autoinhibition of release combined with increased DAT expression/function (Novick et al., 2011 (Novick et al., , 2015 would result in a persistent reduction in synaptic dopamine availability in the adult mPFC, promoting the hypofunctional state caused by adolescent defeat (Figure 9) .
Finally, even though we restricted the infusion of quinpirole and measurement of dopamine to the infralimbic mPFC, it is possible that other brain regions may have contributed in an additive manner to the difference observed between previously defeated and control rats. For example, postsynaptic D2 receptors have a markedly higher affinity for dopamine compared to D1 receptors (Marcellino, Kehr, Agnati, & Fuxe, 2012) , and there is a negative feedback loop consisting of a postsynaptic D2 receptor-mediated inhibition of mPFC glutamatergic projections to the ventral tegmental area (VTA) (Harte & O'Connor, 2004) . Reducing the level of extracellular dopamine via quinpirole could preferentially favor activation of postsynaptic D2 receptors, causing enhanced inhibition of glutamatergic output and a further decrease in VTA neuronal firing to prolong the initial effects of autoreceptor activation. This is supported by the finding that postsynaptic D2 receptor activation in the mPFC does not decrease glutamate levels in the VTA until 40 min postdrug administration (Harte & O'Connor, 2004) . In our study, decreases in dopamine were evident within 5-10 min, consistent with effects posited to be caused by autoreceptor activation (Doherty & Gratton, 1999) , but remained depressed for a further 60 min. Thus, it is possible that the rapid yet sustained decrease in dopamine release seen in defeated rats represents Stress-evoked dopamine release during and after the adolescent stress experience is thought to lead to over-activation of D2 autoreceptors (D2AR). The resulting increase to D2AR function in adulthood can decrease synaptic dopamine availability through a variety of mechanisms.
[1] Greater D2AR function enhances inhibition of voltage-gated calcium channels (VGCC), decreasing vesicular docking at the membrane and augmenting the prevention of dopamine release. In addition, D2AR-mediated ERK1/2 signaling can increase dopamine transporter (DAT) activity.
[2] D2AR activation can also initiate transcription factors for DAT (Nurr1) and facilitate cell surface DAT expression through direct protein-protein interactions.
[3] Enhanced DAT function, resulting from increased expression and activity, increases dopamine reuptake.
[4] However, inhibition of dopamine release and greater dopamine reuptake does not appear to influence tyrosine hydroxylase activity though enhanced end-production inhibition of dopamine synthesis.
[5] Decreased synaptic dopamine availability would lead to [6] decreased postsynaptic D1 and D2 receptor activation, and [7] the observed behavioral implications of hypofunctional dopaminergic signaling. See text for references a combination of initial autoreceptor-mediated effects followed by enhanced negative feedback at the level of the VTA.
We hypothesize that the enhanced autoreceptor function caused by adolescent defeat has direct consequences for behavior (Figure 9 ), such as the working memory deficits shown by previously defeated rats . Specifically, greater autoinhibition would dampen phasic and tonic dopamine release in the mPFC, reducing dopamine availability and subsequent activation of postsynaptic receptors during cognitive tasks. In particular, a decrease in dopamine D1 receptor activity would lead to excessive noise from competing non-relevant networks (Arnsten & Rubia, 2012; Robbins & Arnsten, 2009 ). Optimal dopaminergic activity in the mPFC is required for many other higher cognitive (executive) functions outside the domain of working memory, including top-down control of mesolimbic pathways that mediate goal-directed behavior (Floresco, 2013; Logue & Gould, 2014; Watt et al., 2017) . For example, insufficient mPFC dopamine activity during reward processing is associated with both increased impulsive choice (Yates et al., 2014) and perseveration in conditioned response despite changes in reward contingency (Floresco, 2013) . In accordance with this, rats defeated in adolescence show enhanced preference for psychostimulantassociated cues even when the drug is no longer available (Burke et al., 2011; Rodriguez-Arias et al., 2017) , along with greater alcohol and cocaine self-administration (Burke & Miczek, 2015; Rodriguez-Arias et al., 2017; Rodríguez-Arias et al., 2017) . Findings from the current and previous studies suggest that targeting D2 autoreceptors along with DAT to restore dopamine availability in the mPFC could lead to more efficacious treatment of the cognitive deficits seen in adult neuropsychiatric disorders promoted by periadolescent stress (Watt et al., 2017) . The adolescent social defeat model may therefore provide an effective preclinical means to test novel and repurposed therapeutics.
